The study demonstrated enhanced antibacterial effects, increased penetration into bacterial cells, and prolonged drug activity compared to its free form, making it a potential treatment for combating resistant bacterial infections and multidrug resistance [156]
Aung MM, et al
The big players While Ozempic seems to be getting most of the press these days, there are several agents on the market for weight loss and diabetes: Common gastrointestinal side effects The most frequently reported gastrointestinal side effects of GLP-1 meds include: Nausea: This is the most common side effect, often occurring during the initial weeks of treatment
It has also been approved to reduce the risk of heart attack, stroke, or death in adults with type 2 diabetes and known heart disease Rybelsus (Tablet): Rybelsus, the first and only oral GLP-1 analog, was approved in 2019 to improve blood sugar regulation in adults with type 2 diabetes Wegovy (Injectable): Wegovy, approved in 2021, is specifically indicated as a weight loss drug in adults with obesity or excess weight, who also have weight-related medical problems These FDA-approved medications have undergone rigorous testing to assess their safety and effectiveness for their respective indications
